4//SEC Filing
Cogan John Francis 4
Accession 0001127602-20-013405
CIK 0000882095other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 5:34 PM ET
Size
8.0 KB
Accession
0001127602-20-013405
Insider Transaction Report
Form 4
Cogan John Francis
Director
Transactions
- Exercise/Conversion
Common Stock
2020-04-06$19.63/sh+2,413$47,367→ 57,273 total - Sale
Common Stock
2020-04-06$79.52/sh−2,413$191,882→ 54,860 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2020-04-06−2,413→ 9,655 totalExercise: $19.63Exp: 2020-05-11→ Common Stock (2,413 underlying)
Footnotes (2)
- [F1]The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- [F2]The options vested quarterly over the first year of service and were fully vested on May 11, 2011.
Documents
Issuer
GILEAD SCIENCES INC
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001319872
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 5:34 PM ET
- Size
- 8.0 KB